➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Colorcon
Moodys
Medtronic

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 7,847,486

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,847,486
Title:LED lighting system
Abstract: A lighting system has an array (100) of at least one light-emitting solid-state element such as a light-emitting diode (LED) or a laser diode. A voltage source (10), which may supply either alternating or direct current, energizes the array. Array state circuitry (125; Q2, R2), electrically connected in series with the array (100), senses at least one state of the array, such as the amount of current passing through the array, or temperature. Secondary circuitry (127; R1, Q1; 200, 201, 202; 200, R4, Q1; 126, 127) is connected in parallel with the array (100). A switching component (Q1; Q1, Q3; 202) adjusts the current passing through the secondary circuitry in accordance with the sensed state of the array such that current through the array is maintained substantially constant. A third, parallel, excess current shunt path may also be provided, in which case so is excess current shunt circuitry, which senses current flowing in the secondary circuitry and shunts current in the secondary circuitry in excess of an excess current threshold to the excess current shunt path, whereby overflow current above a first threshold for the array (100) is shunted away from the array and excess current above a second threshold is shunted from the secondary circuits to the excess current shunt circuitry. A wide-angle mounting arrangement is also provided for the array.
Inventor(s): Ng; James K. (Seattle, WA)
Assignee: Dr. LED (Holdings), Inc (Tortola, VG)
Application Number:11/659,295
Patent Claims:see list of patent claims

Details for Patent 7,847,486

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Dr. LED (Holdings), Inc (Tortola, VG) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.